Sign In
20 Jun 2019 16:29
20 June 2019
Cello Health plc
("Cello" or the "Group")
Director/PDMR Shareholding
The Group announces that, on 20 June 2019, certain directors and persons discharging managerial responsibilities (PDMRs) of the Group exercised 10p options over a total of 965,000 ordinary shares of 10 pence each ("Ordinary Shares") pursuant to the Group's PSP Option Scheme 2010, and subsequently sold 600,100 Ordinary Shares at a price of 126.6 pence per Ordinary Share. Details of the option exercises, share sales and resultant shareholdings are set out below:
Name | Title | Options exercised | Ordinary Sharessold | Resultant holding | Percentage of issued share capital |
Mark Scott | Chief Executive | 450,000 | 265,500 | 1,649,975 | 1.5% |
Mark Bentley | Finance Director | 220,000 | 129,800 | 532,718 | 0.5% |
Stephen Highley | COO | 220,000 | 129,800 | 2,226,304 | 2.1% |
Andy Brown | Deputy Finance Director | 75,000 | 75,000 | 6,160 | 0.01% |
The new Ordinary Shares have been issued pursuant to the Group's existing block listing and, as at 20 June 2019, Cello's issued share capital comprises 106,530,309 Ordinary Shares, of which 453,000 Ordinary Shares are held in treasury. The Group's total number of voting rights is therefore 106,077,309 Ordinary Shares, which may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the Group under the FCA's Disclosure Guidance and Transparency Rules.
This announcement contains inside information.
Enquiries:
Cello Health plc | 020 7812 8460 |
Mark Scott, Chief Executive | |
Mark Bentley, Finance Director | |
Cenkos Securities plc | 0207 397 8900 |
Mark Connelly Harry Hargreaves | |
Notes to Editors
Cello Health plc is a global healthcare-focused advisory Group comprised of a set of leading clinical, commercial advisory and digital delivery capabilities. Cello Health plc currently services 24 of the top 25 pharmaceutical clients globally, as well as a wide range of biotech, diagnostics, devices and other key non-healthcare clients.
Cello Health plc enables clients to commercialise and differentiate their assets and drive brand success in ever more complex global markets. The business delivers its services through nearly 1,000 highly skilled professionals, utilising latest thinking, technology and digital solutions.
Cello Health plc delivers its services from an office network in the UK, USA, and Asia, with hub offices in New York City, Philadelphia PA, London, Edinburgh, Farnham and Cheltenham.
For further information, please visit: https://cellohealthplc.com
1 | Details of the person discharging managerial responsibilities / person closely associated | ||||
a) | Name | Mark Scott | |||
2 | Reason for the notification | ||||
a) | Position/status | Chief Executive | |||
b) | Initial notification /Amendment | Initial notification | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a) | Name | Cello Health plc | |||
b) | LEI | 2138004TZYGZLWQP7N64 | |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a)
| Description of the financial instrument, type of instrument | Options over ordinary shares of 10 pence each | |||
Identification code | ISIN: GB00B0310763 | ||||
b) | Nature of the transaction | Exercise of options | |||
c)
| Price(s) and volume(s) | ||||
Price(s) | Volume(s) | ||||
10 pence | 450,000 | ||||
d)
| Aggregated information | ||||
- Aggregated volume | 450,000 | ||||
- Price | £45,000.00 | ||||
e) | Date of the transaction | 20 June 2019 | |||
f) | Place of the transaction | Outside of a trading venue (XOFF) | |||
1 | Details of the person discharging managerial responsibilities / person closely associated | ||||
a) | Name | Mark Scott | |||
2 | Reason for the notification | ||||
a) | Position/status | Chief Executive | |||
b) | Initial notification /Amendment | Initial notification | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a) | Name | Cello Health plc | |||
b) | LEI | 2138004TZYGZLWQP7N64 | |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a)
| Description of the financial instrument, type of instrument | Ordinary shares of 10 pence each | |||
Identification code | ISIN: GB00B0310763 | ||||
b) | Nature of the transaction | Sale of ordinary shares | |||
c)
| Price(s) and volume(s) | ||||
Price(s) | Volume(s) | ||||
126.6 pence | 265,000 | ||||
d)
| Aggregated information | ||||
- Aggregated volume | 265,000 | ||||
- Price | £336,123.00 | ||||
e) | Date of the transaction | 20 June 2019 | |||
f) | Place of the transaction | AIMX | |||
1 | Details of the person discharging managerial responsibilities / person closely associated | ||||
a) | Name | Mark Bentley | |||
2 | Reason for the notification | ||||
a) | Position/status | Finance Director | |||
b) | Initial notification /Amendment | Initial notification | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a) | Name | Cello Health plc | |||
b) | LEI | 2138004TZYGZLWQP7N64 | |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a)
| Description of the financial instrument, type of instrument | Options over ordinary shares of 10 pence each | |||
Identification code | ISIN: GB00B0310763 | ||||
b) | Nature of the transaction | Exercise of options | |||
c)
| Price(s) and volume(s) | ||||
Price(s) | Volume(s) | ||||
10 pence | 220,000 | ||||
d)
| Aggregated information | ||||
- Aggregated volume | 220,000 | ||||
- Price | £22,000.00 | ||||
e) | Date of the transaction | 20 June 2019 | |||
f) | Place of the transaction | Outside of a trading venue (XOFF) | |||
1 | Details of the person discharging managerial responsibilities / person closely associated | ||||
a) | Name | Mark Bentley | |||
2 | Reason for the notification | ||||
a) | Position/status | Finance Director | |||
b) | Initial notification /Amendment | Initial notification | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a) | Name | Cello Health plc | |||
b) | LEI | 2138004TZYGZLWQP7N64 | |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a)
| Description of the financial instrument, type of instrument | Ordinary shares of 10 pence each | |||
Identification code | ISIN: GB00B0310763 | ||||
b) | Nature of the transaction | Sale of ordinary shares | |||
c)
| Price(s) and volume(s) | ||||
Price(s) | Volume(s) | ||||
126.6 pence | 129,800 | ||||
d)
| Aggregated information | ||||
- Aggregated volume | 129,800 | ||||
- Price | £164,326.80 | ||||
e) | Date of the transaction | 20 June 2019 | |||
f) | Place of the transaction | AIMX | |||
1 | Details of the person discharging managerial responsibilities / person closely associated | ||||
a) | Name | Stephen Highley | |||
2 | Reason for the notification | ||||
a) | Position/status | COO | |||
b) | Initial notification /Amendment | Initial notification | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a) | Name | Cello Health plc | |||
b) | LEI | 2138004TZYGZLWQP7N64 | |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a)
| Description of the financial instrument, type of instrument | Options over ordinary shares of 10 pence each | |||
Identification code | ISIN: GB00B0310763 | ||||
b) | Nature of the transaction | Exercise of options | |||
c)
| Price(s) and volume(s) | ||||
Price(s) | Volume(s) | ||||
10 pence | 220,000 | ||||
d)
| Aggregated information | ||||
- Aggregated volume | 220,000 | ||||
- Price | £22,000.00 | ||||
e) | Date of the transaction | 20 June 2019 | |||
f) | Place of the transaction | Outside of a trading venue (XOFF) | |||
1 | Details of the person discharging managerial responsibilities / person closely associated | ||||
a) | Name | Stephen Highley | |||
2 | Reason for the notification | ||||
a) | Position/status | COO | |||
b) | Initial notification /Amendment | Initial notification | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a) | Name | Cello Health plc | |||
b) | LEI | 2138004TZYGZLWQP7N64 | |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a)
| Description of the financial instrument, type of instrument | Ordinary shares of 10 pence each | |||
Identification code | ISIN: GB00B0310763 | ||||
b) | Nature of the transaction | Sale of ordinary shares | |||
c)
| Price(s) and volume(s) | ||||
Price(s) | Volume(s) | ||||
126.6 pence | 129,800 | ||||
d)
| Aggregated information | ||||
- Aggregated volume | 129,800 | ||||
- Price | £164,326.80 | ||||
e) | Date of the transaction | 20 June 2019 | |||
f) | Place of the transaction | AIMX | |||
1 | Details of the person discharging managerial responsibilities / person closely associated | ||||
a) | Name | Andy Brown | |||
2 | Reason for the notification | ||||
a) | Position/status | Deputy Finance Director | |||
b) | Initial notification /Amendment | Initial notification | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a) | Name | Cello Health plc | |||
b) | LEI | 2138004TZYGZLWQP7N64 | |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a)
| Description of the financial instrument, type of instrument | Options over ordinary shares of 10 pence each | |||
Identification code | ISIN: GB00B0310763 | ||||
b) | Nature of the transaction | Exercise of options | |||
c)
| Price(s) and volume(s) | ||||
Price(s) | Volume(s) | ||||
10 pence | 75,000 | ||||
d)
| Aggregated information | ||||
- Aggregated volume | 75,000 | ||||
- Price | £7,500.00 | ||||
e) | Date of the transaction | 20 June 2019 | |||
f) | Place of the transaction | Outside of a trading venue (XOFF) | |||
1 | Details of the person discharging managerial responsibilities / person closely associated | ||||
a) | Name | Andy Brown | |||
2 | Reason for the notification | ||||
a) | Position/status | Group FC and CFO | |||
b) | Initial notification /Amendment | Initial notification | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a) | Name | Cello Health plc | |||
b) | LEI | 2138004TZYGZLWQP7N64 | |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a)
| Description of the financial instrument, type of instrument | Ordinary shares of 10 pence each | |||
Identification code | ISIN: GB00B0310763 | ||||
b) | Nature of the transaction | Sale of ordinary shares | |||
c)
| Price(s) and volume(s) | ||||
Price(s) | Volume(s) | ||||
126.6 pence | 75,000 | ||||
d)
| Aggregated information | ||||
- Aggregated volume | 75,000 | ||||
- Price | £94,950.00 | ||||
e) | Date of the transaction | 20 June 2019 | |||
f) | Place of the transaction | AIMX | |||
Follow the stocks
